MedTrace Logo

Development of a Deaf Child With a Cochlear Implant.

NCT02539901 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 73

Last updated 2015-09-03

No results posted yet for this study

Summary

Cochlear implantation enables profoundly deaf children to acquire speech and develop their understanding of spoken language. However, there are significant interindividual differences in the results obtained with the implant. Given the lack of theoretical knowledge on acoustic predictors, cognitive and language to obtain optimum speech recognition with cochlear implants associated with a good communicative and language development of deaf children, the investigators intend to achieve a preliminary longitudinal study aimed to describe the cognitive, communicative and perceptive implanted deaf children.

The main objective of our study is to describe the cognitive and communicative development of deaf children implanted from the pre-implant assessment to 18 months post-implantation, by addressing the following aspects:

* The psychomotor and cognitive development assessed using the Brunet-Lézine test;
* The development of preverbal communication, evaluated using the Early Social Communication Scale.

Conditions

  • Deafness

Interventions

BEHAVIORAL

Evaluation of the detection of non-linguistic sounds

Evaluation of the detection of non-linguistic sounds (sound room)

BEHAVIORAL

Free hearing test categorization

Free hearing test categorization evaluation

BEHAVIORAL

Early Social Communication Scale (ECSP)

Early Social Communication Scale (ECSP) evaluation

BEHAVIORAL

psychomotor infancy development scale

BEHAVIORAL

NEPSY (two domains: "memory and learning" and "attention and executive functions").

NEPSY evaluation

Sponsors & Collaborators

  • University Hospital, Toulouse

    lead OTHER

Principal Investigators

  • Olivier DEGUINE, MD, PhD · Service ORL - Hôpital Purpan

Eligibility

Min Age
12 Months
Max Age
9 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2014-10-31
Completion
2014-10-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02539901 on ClinicalTrials.gov